CG
AMPH icon

Cutler Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Cutler Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100
Closed -$1.87K – 4813
2017
Q3 		$1K Sell
100
-400
-80% -$6.58K ﹤0.01% 5316
2017
Q2 		$8K Hold
500
– – ﹤0.01% 4337
2017
Q1 		$7K Sell
500
-200
-29% -$3.15K ﹤0.01% 4354
2016
Q4 		$12K Sell
700
-1,800
-72% -$35K ﹤0.01% 3969
2016
Q3 		$47K Buy
+2,500
New +$45.4K ﹤0.01% 2524

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cutler Group's AMPH Position: Q4 2017 in Review

Cutler Group sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2017, closing a stake of 100 shares — an estimated $1.87K sold.

Cutler Group first reported a position in AMPH in Q3 2016 and held it in 5 quarters. The position peaked at $47K in Q3 2016. 109 funds tracked by Wall St. Rank hold AMPH as of Q4 2017.

  • Cutler Group reported no remaining Amphastar Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 100 Amphastar Pharmaceuticals shares in Q4 2017, an estimated $1.87K.
  • Cutler Group first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 5 quarters.
  • Cutler Group's Amphastar Pharmaceuticals position peaked at $47K in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.